The Impact of Aprotinin on Coronary Artery Bypass Graft Patency

This publication has 13 references indexed in Scilit:

• Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving
  The Annals of Thoracic Surgery, 1992
• Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study
  The Annals of Thoracic Surgery, 1992
• Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations
  The Annals of Thoracic Surgery, 1991
• Aprotinin in cardiac surgery
  The Lancet, 1991
• Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization
  Anesthesiology, 1990
• High-Dose Aprotinin: Hemostatic Effects in Open Heart Operations
  The Annals of Thoracic Surgery, 1989
• Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients
  The Thoracic and Cardiovascular Surgeon, 1989
• Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary Results
  The Thoracic and Cardiovascular Surgeon, 1989
• Sensitivity and specificity of assessing coronary bypass graft patency with ultrafast computed tomography: Results of a multicenter study
  Journal of the American College of Cardiology, 1988
• PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASS
  The Lancet, 1988